Are the newer atypical antipsychotics (Zyprexa, etc) better than the older agents for schizophrenia

November 2005

Are the newer atypical antipsychotics (Zyprexa, etc) better than the older agents for schizophrenia?

Many patients on antipsychotics get atypicals...because they're thought to be better tolerated or more effective.

Now a big gov't study, CATIE, suggests newer atypicals are not much better than perphenazine (Trilafon).

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote